← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

Director James Arthur Bristol sold $352K of Deciphera Pharmaceuticals, Inc.

Sold$352,039
$50.29Price
7,000Shares
−100%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Fri, Jan 15. Filed Wed, Jan 20, 11:00 AM ET, during the session. Not investment advice.